EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   3.5.3.18 | Renal Insufficiency, Chronic |
24125425 |
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. |
causal interaction
unassigned |
4
0 |
| 3.5.3.18 | Diabetes Mellitus, Type 2 |
22558392 |
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.5.3.18 | Insulin Resistance |
22558392 |
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.5.3.18 | Coronary Artery Disease |
31409409 |
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 3.5.3.18 | Myocardial Infarction |
31409409 |
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients. |
causal interaction
diagnostic usage
unassigned |
4
4
0 |
| 3.5.3.18 | Carcinoma, Hepatocellular |
28741166 |
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. |
causal interaction
unassigned |
3
0 |
| 3.5.3.18 | Neoplasms |
28741166 |
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1. |
causal interaction
unassigned |
3
0 |
| 3.5.3.18 | Coronary Disease |
20167924 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 3.5.3.18 | Stroke |
20167924 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 3.5.3.18 | Thrombosis |
20167924 |
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
